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Isotope-based methods are commonly used for metabolic
ﬂux analysis and metabolite quantiﬁcation in biological
extracts. Nuclear magnetic resonance (NMR) spectros-
copy is a powerful analytical tool for these studies because
NMR can unambiguously identify compounds and ac-
curately measure 13C enrichment. We have developed
a new pulse sequence, isotope-edited total correlation
spectroscopy (ITOCSY), that ﬁlters two-dimensional
1H-1H NMR spectra from 12C- and 13C-containing
molecules into separate, quantitatively equivalent spec-
tra. The ITOCSY spectra of labeled and unlabeled
molecules are directly comparable and can be assigned
using existing bioinformatics tools. In this study, we
evaluate ITOCSY using synthetic mixtures of standards
and extracts from Escherichia coli. We show that
ITOCSY has low technical error (6.6% for metabolites
ranging from 0.34 to 6.2 mM) and can detect mol-
ecules at concentrations less than 10 µM. We propose
ITOCSY as a practical NMR strategy for metabolic ﬂux
analysis, isotope dilution experiments, and other meth-
ods that rely on carbon-13 labeling.
Nuclear magnetic resonance (NMR) spectroscopy is one of
the primary analytical tools used for investigating metabolites in
complex biological extracts. Recent advances in NMR techniques,
1
data analysis software,
2,3 and spectroscopic libraries of metabolite
standards
4,5 have considerably increased the number of metabo-
lites that can be identiﬁed and quantiﬁed in routine studies.
Currently, more than 80% of the signals observed in 2D 1H-13C
spectra of biological extracts can be assigned,
1 and hundreds
of spectra can be analyzed in a few hours.
2 However, these
tools are primarily constrained to steady-state analyses of
metabolites.
A wide variety of isotope-based methods have been developed
for tracing metabolic pathways,
6 measuring reaction kinetics,
7 and
quantifying molecules after extensive sample handling.
8 These
techniques are of obvious utility to metabolomics but have not
been widely applied to NMR-based studies because of complica-
tions related to signal overlap. NMR spectra of unenriched
biological extracts can contain thousands of 1H resonances. Spectra
of 13C-enriched extracts are further complicated by 1H-13C
J-couplings. In isotope-based metabolomics studies, which involve
complex mixtures of both 13C-labeled and unlabeled metabolites,
NMR spectra are too heavily overlapped to support comprehen-
sive quantitative analyses. As a result, studies that have employed
isotope-based methods have been restricted to the subset me-
tabolites with well-isolated resonances.
9-11
To make isotope-based techniques more accessible to com-
prehensive metabolic analyses, we have developed a homonuclear
1H NMR experiment that separates signals from 12C- and 13C-
containing molecules into distinct, quantitatively equivalent
spectra. This pulse sequence, isotope-edited total correlation
spectroscopy (ITOCSY), allows metabolomics studies to capi-
talize on isotope-based methods without increasing the com-
plexity of spectra. ITOCSY is based on the established TOCSY
pulse sequence,
12-14 which is desirable for metabolomics
11,15-19
because of its high sensitivity and compatibility with existing
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2-5,20 We introduce
the ITOCSY pulse sequence and evaluate its performance under
both controlled and biologically relevant conditions. We show that
ITOCSY is a reliable quantitative tool, and we foresee its potential
utility in metabolic ﬂux analysis, isotope dilution experiments, and
other methods that rely on isotopic labeling.
EXPERIMENTAL SECTION
Strategy for Isotope Ratio-Based Quantiﬁcation. This study
uses an NMR adaptation of the traditional isotope dilution method
for quantifying metabolites.
8 Isotope dilution studies derive
concentration from the ratio of a metabolite’s signal to the signal
from an isotope-labeled standard. Multiplying the observed isotope
ratio by the amount of standard added allows one to calculate the
amount of metabolite present in the sample at the time the
standard was added.
8 In metabolomics studies, each observable
metabolite is standardized against an isotopically enriched version
of the same molecule. Alternatively, isotopically enriched extracts
can be standardized against unlabeled molecules.
We used both the 12C- and 13C-standardized isotope dilution
approaches in this study. To evaluate the qualitative perfor-
mance and quantitative accuracy of ITOCSY-derived isotope
ratios, we used 24 complex synthetic mixtures of unlabeled
metabolites containing varying amounts of 13C-labeled mol-
ecules (Table S-1 in Supporting Information). We calculated the
concentrations of the 13C-labeled metabolites by isotope dilution
and compared them to the known concentrations of each
molecule. We then applied ITOCSY to a metabolic investigation
of the osmotic stress response in Escherichia coli. We describe
how a mixture of 13C-labeled metabolites isolated from E. coli
cells grown on [U-13C] glucose can be calibrated for use as a
standard.
ITOCSY Pulse Sequence. ITOCSY data are collected as two
1H-1H DIPSI-TOCSY spectra,
12-14 one speciﬁc to 12C and the
other isotopically nonspeciﬁc (12C + 13C). Signals from 13C-
bound protons are removed from 12C-speciﬁc spectra by the
use of 90°(1H)-1/41JHC-180°(1H,13C)-1/41JHC-90°(13C)-PFG
ﬁlter elements. These low-pass J-ﬁlters convert antiphase 13C-
bound 1H magnetization to undetectable double- and zero-
quantum coherence.
21 ITOCSY employs three consecutive
ﬁltering elements with 1/41JHC delays tuned to aromatic (170
Hz), aliphatic (140 Hz), and anomeric (125 Hz) coupling
constants (Figure 1). Isotopically nonspeciﬁc spectra are collected
using the same pulse sequence but with the carbon transmitters
tuned 300 ppm off resonance to prevent the ﬁltering elements
from functioning. This approach ensures that the complementary
spectra are collected under identical conditions. 12C + 13C and
12C data are collected in interleaved scans, and both utilize
carbon decoupling to minimize spectral complexity. 13C-speciﬁc
data are derived as a difference spectrum from the nonspeciﬁc
(12C + 13C) and 12C-speciﬁc spectra.
Preparation of Synthetic Mixtures. We evaluated the quan-
titative efﬁcacy of ITOCSY by analyzing synthetic mixtures
containing both 13C-labeled and unlabeled standards prepared
at known concentrations. Synthetic mixtures (N ) 24) con-
tained 30 biologically relevant compounds, six of which
included both U-13C-labeled and unlabeled species. These
differentially labeled compounds were alanine, fructose, glu-
cose, glutamate, glutamine, and lactate. All unlabeled molecules
were prepared at 2 mM, and the concentrations of the U-13C
compounds ranged from 130 µM to 6.5 mM (Table S-1 in
Supporting Information). All synthetic samples were prepared
in D2O containing 300 µM NaN3 (to inhibit microbial growth)
and 300 µM DSS (4,4-dimethyl-4-silapentane-1-sulfonic acid, the
NMR chemical shift standard). Samples were titrated with DCl/
NaOD as needed to achieve an observed (glass electrode) pH
of 7.400 ± 0.004.
In Vivo Isotopic Labeling Strategy. ITOCSY-based quanti-
ﬁcation requires isotopically labeled standards, but it is impractical
to purchase the number of enriched compounds required for
comprehensive metabolic analyses. For the osmotic stress study
(see below), [U-13C] standards were produced in vivo from E.
coli incubated in [U-13C]-glucose under the control condition.
To quantify metabolites in the labeled extracts, a second set
of unlabeled cultures was grown from the same starter in a
medium containing unlabeled glucose. Metabolites in the
unlabeled cultures were quantiﬁed using established methods,
1
and these levels were used as a benchmark for the labeled
extracts. Regression coefﬁcients used for quantifying enriched
(20) Cui, Q.; Lewis, I. A.; Hegeman, A. D.; Anderson, M. E.; Li, J.; Schulte, C. F.;
Westler, W. M.; Eghbalnia, H. R.; Sussman, M. R.; Markley, J. L. Nat.
Biotechnol. 2008, 26, 162–164.
(21) Kogler, H.; Sørensen, O. W.; Bodenhausen, G.; Ernst, R. R. J. Magn. Reson.
1983, 55, 157–163.
Figure 1. Pulse program for acquiring ITOCSY. Filled and open bars
indicate nonselective 90 and 180° hard pulses, respectively. Shaped
13C pulses denote 1 ms (200 ppm) hyperbolic secant inversions.
28
Spectra are acquired with the 1H carrier set on resonance with the
residual water signal (4.77 ppm). Isotope-speciﬁc and nonspeciﬁc data
are collected on alternate scans; ﬁltered data are collected with the
13C carrier set on resonance (70 ppm), and isotopically nonspeciﬁc
data are collected with the 13C carrier set off resonance (300 ppm)
for pulses between points a and b. The τ1, τ2, and τ3 delays are set
to 1/4 1JHC with the ﬁltering elements optimized for 125, 140, and
170 Hz coupling constants. All 13C pulses are placed on resonance
after point b for 13C decoupling; a composite pulse (90x-180y-90x)
and a WURST CPD sequence
29 (140 ppm) are used for 13C
decoupling during the t1 and t2 evolution periods, respectively. Isotopic
mixing is achieved via the DIPSI-2 sequence
13 with a bandwidth of 4
kHz and a length of 80 ms. Pulses are applied along the x-axis unless
otherwise indicated. Phase cycling for φ1 ) x,-x; φ2 ) x,x,-x,-x; φ3
) x,x,x,x,-x,-x,-x,-x; φrec ) x,-x,-x,x,-x,x,x,-x. To achieve
quadrature detection for the 1H indirect dimension, a second FID is
collected for each increment with the phase cycling for φ1 set to y
and -y; states-TPPI requires the φ1 and φrec phases to alternate by
180° every other increment. Pulse ﬁeld gradients (PFG) employ
shaped z-axis WURST pulses applied for 1.0 ms. Gradients G1,G 3,
and G5 select magnetization inverted by the 180° 1H pulses and are
varied between 2 and 5 G/cm. Gradients G2,G 4,G 6, and G7 destroy
xy-plane magnetization and are set to 7, 9, 11, and 5 G/cm,
respectively. The Varian pulse program used in this study is available
from www.nmrfam.wisc.edu/software.
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enriched extracts prepared at three dilutions (1:0, 1:1, 1:3) in
D2O.
Osmotic Stress Study. As a biological application of ITOCSY,
we investigated the metabolic response of E. coli incubated under
varying levels of osmotic stress. Cultures (500 mL each; N ) 4
per condition) of E. coli (MG1655) were grown in M9 media
containing 22.8 mM glucose and variable concentration of salt: 0
(control), 150, 300, or 500 mM NaCl. To probe the dependence
of the observed metabolic responses on osmolarity, we prepared
additional cultures (N ) 4) in M9 medium containing 500 mM
NaCl and 10 mM glycine betaine, an established osmoprotectant.
22
Isotopically enriched cultures used for metabolite standards (250
mL each; N ) 20) were grown in M9 medium containing 22.1
mM [U-13C]-glucose (Cambridge Isotope Laboratories). All
cultures were incubated on a shaking platform at 37 °C. When
cultures reached an optical density of 0.80 (660 nm), they were
transferred to an ice-water bath to minimize metabolic activity.
All subsequent sample preparation was conducted in a 4 °C
cold room. Chilled samples (500 mL for natural abundance,
250 mL for 13C cultures) were centrifuged (18 500g), and the
supernatant was discarded. Pellets were washed with 10 mL
of glucose-free M9 media osmotically adjusted with NaCl to
match each of the culture conditions. Washed pellets were
recentrifuged, and the resulting pellets were ﬂash frozen in
liquid N2.
Preparation of Biological Extracts. Frozen E. coli pellets
were resuspended in 16 mL of boiling water containing 250 µM
MES. Samples were incubated in sealed reaction vials in a boiling
water bath for 7.5 min, then centrifuged to remove cellular debris
(8000g). The pellet was discarded, and extracts were microﬁltered
(Vivaspin 20; 3000 MWCO) to remove high molecular weight
components. Filtrates were lyophilized and redissolved in 800 µL
of D2O with 300 µM NaN3 and 300 µM DSS. Samples were
titrated with DCl/NaOD as needed to an observed pH of 7.400
(±0.004). All 13C-labeled samples were pooled to create a single
13C-enriched library. Labeled standards were mixed with
unlabeled samples (300 µL each) and transferred to 5 mm NMR
tubes (Wilmad) for spectroscopic analysis.
NMR Spectroscopy. All NMR spectroscopy was conducted
at the National Magnetic Resonance Facility at Madison. Two-
dimensional 1H-1H ITOCSY spectra were collected on a 600
MHz Varian spectrometer equipped with a cryogenic probe.
Spectra were collected with a 1.5 s repetition delay, 64 steady-
state transits, 2 acquisition transits, 128 increments, and an
acquisition time of 0.5 s (7530 points). Sweep widths for the
direct and indirect dimensions were 7500 and 5400 Hz,
respectively. 12C + 13C and 12C-speciﬁc spectra were collected
concurrently using interleaved scans. Time-domain data were
Fourier transformed with a shifted sine bell window function,
zero-ﬁlled, phased, and referenced to DSS using automated
NMRPipe
23 macros written in-house. 13C-speciﬁc difference
spectra were derived from the 12C + 13C and 12C-speciﬁc data
using custom NMRPipe macros.
Metabolite Quantiﬁcation. All NMR data analyses were
performed using the rNMR software package.
2 Metabolite signals
in ITOCSY spectra were assigned using previously established
methods.
1 Brieﬂy, metabolites were identiﬁed by submitting peak
lists to the Madison Metabolomics Consortium Database;
20
possible metabolite matches were veriﬁed by visually inspecting
overlaid spectral standards from the BioMagResBank.
4 Dispersed
resonances were selected for each of the assigned metabolites,
and the peak intensities of these signals were measured.
Deriving accurate metabolite concentrations from multidimen-
sional NMR signal intensities requires the use of calibration
coefﬁcients.
1 These isotope- and resonance-speciﬁc coefﬁcients
(m12, m13) are the linear regression slopes describing concen-
tration as a function of intensity (∆concentration/∆intensity)
for metabolite signals in standards prepared at three concentra-
tions. In the E. coli study, m12 was calculated from the signals
of unlabeled standards prepared at 2, 5, and 10 mM; m13 was
calculated from signals of 13C-enriched metabolite extracts
prepared at 1:0, 1:1, and 1:3 dilutions. Calibration coefﬁcients
in the synthetic samples were calibrated independently using
standards prepared at the minimum, median, and maximum
concentration of each metabolite in the synthetic mixtures
(Table S-1 in Supporting Information).
Metabolite concentrations were calculated from ITOCSY
signals via three methods (eqs 1-3). The established fast
metabolite quantiﬁcation (FMQ) method,
1 which was used as a
benchmark for E. coli study, determines the total concentration
(Utot) of unlabeled (U12) and natural abundance 13C( Una)
resonances from signal intensities (I12) observed in 12C-speciﬁc
ITOCSY spectra (eq 1).
Utot ) U12 + Una ) I12 × m12 (1)
Metabolites were also quantiﬁed using the calibrated ITOCSY
method (eqs 2 and 3), which relates unenriched signals (I12)t o
the corresponding resonances from [U-13C]-labeled molecules
(I13). The calibrated ITOCSY approach can be used to either
(eq 2) calculate concentrations of enriched molecules (U13)
relative to known concentrations of unenriched standards (S12)
or (eq 3) calculate concentrations of unenriched molecules (Utot)
relative to concentrations of [U-13C] standards (S13). The
equations used for calibrated ITOCSY calculations differ
between S12- and S13-standarized experiments to account for
the natural abundance levels of 13C (1.1%) in unenriched
molecules. In this study, the S12 protocol (eq 2) was used for
calculating metabolite concentrations in synthetic mixtures whereas
the S13 protocol (eq 3) was used in the E. coli study.




Utot ) S13 × {
I12 × m12
I13 × m13 - (I12 × m12 × 0.011)} (3)
RESULTS AND DISCUSSION
We used complex mixtures of standards prepared with [U-13C]-
labeled and unlabeled compounds (Table S-1 in Supporting
Information) to investigate the efﬁcacy of ITOCSY-based analyses.
As expected, ITOCSY was effective for separating resonances on
(22) Cayley, S.; Record, M. T. Biochemistry 2003, 42, 12596–12609.
(23) Delaglio, F.; Grzesiek, S.; Vuister, G. W.; Zhu, G.; Pfeifer, J.; Bax, A.
J. Biomol. NMR 1995, 6, 277–293.
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had hoped that quantiﬁcation based on 13C/12C ratios for
individual resonances would normalize the systematic quantita-
tive defects inherent to multidimensional NMR
1 and eliminate
the need for external signal calibration. Although enrichment-
based quantiﬁcation eliminated several major sources of
systematic error, differential T1 relaxation and other isotope-
related phenomena prevented accurate quantiﬁcation from the
uncalibrated ITOCSY signals.
We previously reported a general method for correcting
systematic quantitative defects in NMR pulse sequences using
empirically determined calibration coefﬁcients.
1 ITOCSY-derived
isotopic ratios were calibrated in this manner using standards
prepared at multiple dilutions. As expected, the corrected 13C/
12C values were quantitatively reliable; regression of 121
ITOCSY-derived concentrations versus known levels yielded
a slope of 0.96 (ideal slope of 1) with R2 ) 0.98. This translates
to 6.6% average technical error for concentrations ranging from
0.34 to 6.2 mM (Figure 4).
To evaluate ITOCSY in the context of a biological study, E.
coli cultures were prepared under varying levels of osmotic stress.
Unlabeled extracts were mixed with a 13C metabolite library, and
compounds were quantiﬁed using the FMQ
1 and corrected
ITOCSY protocols. FMQ-based values were calculated from
signals observed in 12C-speciﬁc ITOCSY spectra, whereas
ITOCSY-based values were calculated from 12C/13C ratios.
Regression of concentrations (N ) 339; 0.009 to 11 mM)
determined by ITOCSY versus FMQ showed a slope of 1.02
and an R2 of 0.99 (Figure 5). Concentration-dependent error was
observed, with values under 100 µM showing a substantial
increase in error. These data indicate that the sensitivity limit of
ITOCSY is less than 10 µM, but the limit for reliable quantiﬁcation
is 100 µM.
ITOCSY-based analyses of the E. coli extracts relied on
isotopically enriched standards produced in vivo. These standards
were quantiﬁed under the assumption that steady-state metabolite
levels observed in labeled and unlabeled extracts are equivalent.
The strong correlation observed between FMQ and ITOCSY
values veriﬁes this assumption. If steady-state levels differed
Figure 2. Isotopically nonspeciﬁc (12C + 13C), difference edited (13C),
and isotope-ﬁltered (12C) 1D 1H-1H ITOCSY spectra of a mixture of
unlabeled and uniformly 13C-labeled molecules. Signals in the 13C
spectrum correspond to [U-13C]-glucose, [U-13C]-glutamine, and
[U-13C]-alanine, whereas signals in the 12C spectrum correspond to
unenriched DSS.
Figure 3. Isotope-ﬁltered (12C) and difference edited (13C) 2D 1H-1H
ITOCSY spectra of a synthetic mixture containing 30 unlabeled and
six 13C-labeled metabolites. Resonance assignments for 13C-enriched
compounds are shown. A complete listing of the unlabeled metabo-
lites and the concentrations of the 13C-enriched compounds are
provided in the Supporting Information (Table S-1, synthetic mixture
1).
Figure 4. Metabolite concentrations (N ) 121) measured by
calibrated 2D 1H-1H ITOCSY vs known values. The dotted line
indicates the ideal regression line (slope ) 1). The data represent
24 synthetic mixtures; each mixture contained 30 metabolite stan-
dards, 6 of which were supplemented with a [U-13C]-labeled version.
ITOCSY values were calculated from the observed 13C/12C ratio and
were corrected for systematic quantitative errors using empirically
derived coefﬁcients. The error estimate reﬂects the average absolute
error for all ITOCSY-derived metabolite concentrations. The composi-
tions of the synthetic mixtures are listed in Supporting Information
Table S-1.
4561 Analytical Chemistry, Vol. 82, No. 11, June 1, 2010between labeled and unlabeled samples, then compound-speciﬁc
systematic error would have been observed.
One limitation of ITOCSY evident from the E. coli study is
that reliable quantiﬁcation requires both the labeled and unlabeled
molecules to be present at concentrations above the detection
limit. Six of the 24 metabolites quantiﬁed by FMQ were not
observable in ITOCSY spectra of the enriched extracts. Four of
these compounds were present at concentrations near the limit
of detection for FMQ and were unobservable in enriched extracts
because of the faster R1 relaxation of 13C-labeled molecules. The
other two compounds, glucose and trehalose, were absent from
the enriched library because these metabolites are only
accumulated under high-salt conditions. The main biological
ﬁndings of this study were salt-dependent increases in trehalose
and glucose, diminished putrescine levels at high salt, and the
reversal of these phenotypes by glycine betaine (Figure 6).
These ﬁndings, which had been previously reported,
24-27 were
not quantiﬁable by isotope dilution because of our design of the
in vivo labeling conditions. This limitation could be mitigated in
future studies by including samples from each condition as
standards.
CONCLUSIONS
ITOCSY was effective in separating signals from labeled and
unlabeled molecules. Although accurate quantiﬁcation required
calibration, the corrected signals had sufﬁciently low error to be
useful for metabolomics studies. We foresee the primary applica-
tions of ITOCSY to be metabolic ﬂux analysis, isotope dilution,
and metabolite quantiﬁcation using standards produced in vivo.
The in vivo labeling strategy used in this study has obvious
applications beyond the limited case presented here. Enriched
metabolites produced in cost-effective systems could be used to
quantify extracts from unrelated species. The 13C-labeled me-
tabolite library generated for this study, for example, could be
used to quantify metabolites in human serum. The main
limitation to this approach is that quantiﬁcation requires
metabolites to be present in both library and test samples.
However, a more comprehensive library could be constructed
using a variety of free-living organisms or under a range of
conditions appropriate to a particular study.
(24) Lewis, B. A.; Cayley, S.; Padmanabhan, S.; Kolb, V. M.; Brushaber, V.;
Anderson, C. F.; Record, M. T. J. Magn. Reson. 1990, 90, 612–617.
(25) Measures, J. C. Nature 1975, 257, 398–400.
(26) Munro, G. F.; Hercules, K.; Morgan, J.; Sauerbie, W. J. Biol. Chem. 1972,
247, 1272–1280.
(27) Record, M. T.; Courtenay, E. S.; Cayley, D. S.; Guttman, H. J. Trends
Biochem. Sci. 1998, 23, 143–148.
(28) Silver, M. S.; Joseph, R. I.; Hoult, D. I. J. Magn. Reson. 1984, 59, 347–351.
(29) Kupe ˇe, E.; Freeman, R. J. Magn. Reson. Ser. A 1995, 115, 273–276.
Figure 5. Metabolite concentrations (N ) 339) and quantitative
errors observed in 20 E. coli extracts as measured by calibrated
ITOCSY vs the established FMQ protocol.
1 Each extract was mixed
1-to-1 with a 13C-enriched E. coli extract. FMQ values were based
on the intensities of 12C-speciﬁc spectra, whereas ITOCSY values
were derived from 12C/13C ratios observed for metabolites in each
mixture. Quantitative errors observed in these data were concentra-
tion-dependent; metabolites with concentrations ranging from 0.010
to 0.1, 0.1 to 0.5, 0.5 to 1, and 1 to 11 mM showed average absolute
errors of 17, 13, 8, and 4%, respectively. A total of 24 compounds
were quantiﬁed in this study; glucose, glutamine, isoleucine, MES,
phenylalanine, and trehalose were excluded from the ﬁgure because
these compounds were not observable in ITOCSY spectra of the 13C-
enriched library. A complete list of metabolite concentrations observed
in the E. coli extracts can be found in Supporting Information Table
S-2.
Figure 6. Osmolarity-dependent alterations in metabolites observed
in 2D 1H-1H ITOCSY spectra (12C-speciﬁc) of E. coli extracts. Each
box shows a metabolite-speciﬁc region of an NMR spectrum; columns
denote the four selected compounds; rows denote the ﬁve conditions
(N ) 4 each) used for E. coli cultures. All spectra are shown with the
minimum and maximum contour thresholds set to 25 and 55 standard
deviations above the thermal noise, respectively. Steady-state con-
centrations of glucose (Gluc) and trehalose (Treh) are elevated under
osmotic stress, whereas putrescine (Putr) levels are diminished.
Samples incubated in 500 mM NaCl with 10 mM glycine betaine (last
four rows) show a metabolic phenotype similar to cultures grown in
standard M9 medium (ﬁrst four rows). Alanine (Ala) signals are shown
as a reference. A complete listing of all of the metabolites quantiﬁed
in this study can be found in Supporting Information Table S-2.
4562 Analytical Chemistry, Vol. 82, No. 11, June 1, 2010The ITOCSY quantiﬁcation protocol is an NMR adaptation of
the traditional radioisotope dilution method for measuring me-
tabolite concentrations.
8 Isotope dilution methods are advanta-
geous because they can correct sample-to-sample variations in
extraction efﬁciency, chromatography, and other sample handling
errors if standards are added prior to any manipulation of the
samples. Although extracts were analyzed as a complex solution
in this study, the ITOCSY quantiﬁcation protocol presented here
allows samples to be fractionated and concentrated without
affecting quantiﬁcation.
Capitalizing on enriched libraries depends on our ability to
quantify the labeled metabolites. ITOCSY provides a simple
mechanism for achieving this; labeled compounds can be identi-
ﬁed by using existing bioinformatics tools and quantiﬁed by using
unlabeled standards. In summary, ITOCSY is a convenient tool
for differentiating between molecules on the basis of enrichment
and provides the framework for extending metabolomics into
comprehensive isotope-based studies.
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